Roche Holding AG (RHHBY) Stock Price, News, Quote & History
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa,…
Roche Holding AG (RHHBY) stock price, news, quote and history
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa,…
Roche expands cyclospora testing portfolio to support U.S. public health response
Roche has launched two new, real-time PCR tests to detect cyclospora, a diarrhea-causing infection, to help meet diverse…
Roche launches 2 cyclospora PCR tests for labs
Roche has launched two new, real-time PCR tests to detect cyclospora, a diarrhea-causing infection, to help meet diverse…
Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis
The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated with…
Roche Gets FDA 510(k) Clearance for BV/CV Test
The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated with…
Roche’s Susvimo Gets EU Approval Recommendation for nAMD
Roche (OTCQX: RHHBY) announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP)…
Roche H1 Results: 6% Growth, Exchange-Rate Adjusted
Roche (OTCQX:RHHBY) reported first-half 2026 Group sales of CHF 30.4 billion, up 6% at constant…
Roche Shows FDA-Cleared Alzheimer’s Test at ADLM
Supporting ADLM’s focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challengesHighlighting innovations in mass spectrometry,…
Roche Appoints Dan Malarek as North America Diagnostics CEO
Dan Malarek, current CEO of Foundation Medicine Inc., appointed President and CEO of Roche Diagnostics North America, effective…
RHHBY’s Gazyva Gets FDA Priority Review for Label Expansion
Roche RHHBY announced that the FDA has granted Priority Review to the company’s supplemental biologics license application (sBLA)…
Roche Gazyva/Gazyvaro Gets FDA Priority Review
Roche (OTCQX:RHHBY) reported that the US FDA granted Priority Review to its supplemental Biologics License…